Spinal cord injury (SCI) remains a major unmet medical challenge, often resulting in permanent paralysis and disability with ...

Lineage Cell Therapeutics, Inc. (($LCTX)) announced an update on their ongoing clinical study. Study Overview: The DOSED clinical study, ...

NervGen's NVG-291 shows promising preclinical results in spinal cord injury, with significant improvements in motor function and nerve regeneration, positioning it as a potential breakthrough in ...

Thiorphan promotes neural regeneration after a spinal cord injury, according to new research published in Nature on Oct. 29.

Our Spinal Cord Injury Program specializes in caring for spinal cord injury patients immediately after the injury and during rehabilitation and recovery. We offer treatment options that are unique in ...

Ninety percent of paralyzed patients regained strength or function in their upper limbs after receiving an experimental therapy, a new study found. After receiving spinal cord simulation from ONWARD ...

A groundbreaking study from UC San Diego has identified Thiorphan, an existing drug, as a potential game-changer for spinal ...

A recent review published in Engineering explores the construction and potential applications of spinal cord and peripheral ...

A spinal cord injury can be life-altering – and the potential for infertility is often a devastating blow as well. Among men who experience spinal cord injuries (SCIs) in the U.S., nearly eight in 10 ...

An experimental study from the University of Birmingham has brought the long-awaited hope of a treatment for acute spinal cord injury (SCI) one step closer. The research involved using an existing ...

Former Boston University hockey player Travis Roy, who was paralyzed after an injury in 1995 and became a philanthropist for spinal cord injury treatment, has died at 45. A family spokesperson told ...